← Back to Patent Explorer
US4347367A Expired / Lapsed US ⏱️ 0.0 years remaining

3-Substituted-6-(1'-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid

Assignee: Merck and Co Inc
•
Filing: 1980-11-14
•
Granted: 1982-08-31
•
Expires: 2000-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 3-substituted-6-(1'-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene- 2-carboxylic acids having the structure: <IMAGE> wherein R8 is, inter alia, selected from the group consisting of hydrogen, alkyl, alkenyl, aryl and aralkyl. Such compounds as well as their pharmaceutically acceptable O- and carboxyl derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 David B. R. Johnston
  • 👤 Susan M. Schmitt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 20:50
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/16; C07D477/20; C07C; C07C205/00; C07C205/39; C07C205/42; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D477/26; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/10

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 146 words
A compound selected from the group consisting of: ##STR83## wherein: R 4 is hydrogen; R 5 is a removable protecting group or a pharamceutically acceptable ester moiety; and R 8 is selected from the group consisting of hydrogen, substituted and unsubstituted: alkyl, alkenyl, and alkynyl, having from 1-10 carbon atoms; cycloalkyl, cycloalkylalkyl and alkylcycloalkyl, having 3-6 carbon atoms in the cycloalkyl ring and 1-6 carbon atoms in the alkyl moieties; phenyl, aralkyl, aralkenyl, and aralkynyl wherein the aryl moiety is phenyl and the linear chain has 1-6 carbon atoms; wherein the substituent or substituents relative to the above-named R 8 radicals are selected from the group consisting of: amino, mono-, di- and trialkylamino, hydroxyl, alkoxyl, mercapto, alkylthio, phenylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano and carboxy; and wherein the alkyl moieties of the above-recited substituents have 1-6 carbon atoms; X is chloro or bromo.
Claim 2
Dependent Claim 146 words
A compound selected from the group consisting of: ##STR83## wherein: R 4 is hydrogen; R 5 is a removable protecting group or a pharamceutically acceptable ester moiety; and R 8 is selected from the group consisting of hydrogen, substituted and unsubstituted: alkyl, alkenyl, and alkynyl, having from 1-10 carbon atoms; cycloalkyl, cycloalkylalkyl and alkylcycloalkyl, having 3-6 carbon atoms in the cycloalkyl ring and 1-6 carbon atoms in the alkyl moieties; phenyl, aralkyl, aralkenyl, and aralkynyl wherein the aryl moiety is phenyl and the linear chain has 1-6 carbon atoms; wherein the substituent or substituents relative to the above-named R 8 radicals are selected from the group consisting of: amino, mono-, di- and trialkylamino, hydroxyl, alkoxyl, mercapto, alkylthio, phenylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano and carboxy; and wherein the alkyl moieties of the above-recited substituents have 1-6 carbon atoms; X is chloro or bromo.
Claim 3
Dependent Claim 68 words
A compound having the structure: ##STR84## wherein: R 5 is a removable protecting group or a pharmaceutically acceptable ester moeity; and R 8 is selected from the group consisting of: H, CH 3 , C(CH 3 ) 2 CH 2 NH 2 , ##STR85## CH 2 CH 2 CH 2 NH 2 , CH 2 CH(CH 3 )NH 2 , ##STR86## CH 2 CH 2 NH 2 ##STR87##
Claim 4
Dependent Claim 68 words
A compound having the structure: ##STR84## wherein: R 5 is a removable protecting group or a pharmaceutically acceptable ester moeity; and R 8 is selected from the group consisting of: H, CH 3 , C(CH 3 ) 2 CH 2 NH 2 , ##STR85## CH 2 CH 2 CH 2 NH 2 , CH 2 CH(CH 3 )NH 2 , ##STR86## CH 2 CH 2 NH 2 ##STR87##

References Cited (Backward Citations)

US4234596A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-08-30 1986-03-01 1986-08-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-08-30 1990-03-01 1990-08-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-08-30 1994-03-01 1994-08-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag